Added to YB: 2024-10-29
Pitch date: 2024-10-28
ECOR [bullish]
electroCore, Inc.
-57.44%
current return
Author Info
No bio for this author
Company Info
electroCore, Inc., a bioelectronic medicine and general wellness company, provides non-invasive vagus nerve stimulation (“nVNS”) technology platform in the United States, the United Kingdom, and internationally.
Market Cap
$36.9M
Pitch Price
$11.16
Price Target
N/A
Dividend
N/A
EV/EBITDA
-3.08
P/E
-3.21
EV/Sales
1.26
Sector
Health Care Equipment and Supplies
Category
growth
ElectroCore Nears Cash Flow Positive Milestone with Expanding Revenue Base
ECOR: Approaching cash flow positive w/ 50%+ revenue growth. <1% VA migraine market penetration. Air Force study shows TAC-STIM improves pilot cognition. Special forces orders boost Q4 rev. Consumer product Truvaga gaining traction. Stock +70% in month, but early stages of growth. PTSD market untapped.
Read full article (1 min)